Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...

Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

In a highly competitive space, AI platforms must now prove themselves through proprietary data, focused pipelines and clinical readouts in competitive diseases. Promises of faster, cheaper drug ...

In this episode of Denatured, you'll listen to Viswa Colluru, CEO and founder of Enveda and Akshay Rai, principal, Healthcare & Biotech Investments at Premji Invest. We speak about how AI platforms ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.

This article describes an automated brain organoid creation workflow using the CellXpress.ai system, beginning with iPSCs and ...